VSR’s methodology is based on translational research and leverages a recursive process continuously analysing the Structure–Activity Relationship (SAR) of natural scaffolds and semi-synthetic new molecular entities to recursively improve their efficacy, selectivity and bioavailability. Notably, new molecular entities developed through this approach usually enjoy a higher patentability. Execution of such methodology is possible thanks to VSR’s multidisciplinary laboratory team (pharmacology, biology, genetics, medicinal chemistry) and established partnerships with leading scientific institutions (e.g. CNR).
25 June 20161 July 2019